Results 151 to 160 of about 690,170 (210)

Doença cardíaca carcinoide [PDF]

Arquivos Brasileiros de Cardiologia, 2013
Gerald Hollander, Jacob Shani, Vijay Shetty, Adnan Sadiq, Ankur Lodha, Sameer Chadha   +5 more
openaire   +4 more sources

A systematic review and meta-analysis of the diagnosis and surgical management of carcinoid heart disease. [PDF]

Front Cardiovasc Med
Namkoong J, Andraweera PH, Pathirana M, Munawar D, Downie M, Edwards S, Averbuj P, Arstall MA.   +7 more
europepmc   +1 more source

C-1 | "The Impact of Pulmonary Hypertension on Survival in Carcinoid Heart Disease: Insights from Invasive Hemodynamic Assessment"

Abdelrahman Ali, Kevin A. Honan, Jong Kun Park, Clarence Gill, Konstantinos Charitakis, Mehmet Çilingiroğlu, Konstantinos Dean Boudoulas, Jaime Alexander Caballero, Konstantinos Marmagkiolis, Cezar Iliescu   +9 more
openalex   +1 more source

Doença cardíaca carcinoide Carcinoid heart disease

Arquivos Brasileiros de Cardiologia, 2013
Sameer Chadha, Ankur Lodha, Vijay Shetty, Adnan Sadiq, Gerald Hollander, Jacob Shani   +5 more
doaj  

Some of the next articles are maybe not open access.

Related searches:

Management of carcinoid heart disease

Current Problems in Cancer
Carcinoid Heart Disease (CaHD) is defined as the constellation of all cardiac manifestations that occur in patients with carcinoid tumors. Cardiac manifestations are generally due to the paraneoplastic effects of vasoactive substances secreted by carcinoid tumors. These primarily cause cardiac valve dysfunction and resultant heart failure.
Madelaine Hack, Castigliano M Bhamidipati   +1 more
openaire   +3 more sources

Carcinoid heart disease [PDF]

Heart, 2017
Rare neuroendocrine tumours (NETs) that most commonly arise in the gastrointestinal tract can lead to carcinoid syndrome and carcinoid heart disease. Patients with carcinoid syndrome present with vasomotor changes, hypermotility of the gastrointestinal system, hypotension and bronchospasm.
Arvind Dasari, Syed Wamique Yusuf, Juan Lopez-Mattei, Jose Banchs, Saamir Hassan, Cezar Iliescu   +5 more
openaire   +2 more sources

Management and outcomes of carcinoid heart disease with liver metastases of midgut neuroendocrine tumours

Heart, 2023
Objective Despite recent advances in surgical and interventional techniques, knowledge on the management of carcinoid heart disease (CHD) remains limited.
G. Suc, A. Cachier, O. Hentic, B. Bazire, A. Sannier, C. Delhomme, P. Nataf, J. Laschet, L. Deschamps, E. Garbarz, P. Ou, G. Caligiuri, B. Iung, P. Ruszniewski, L. de Mestier, D. Arangalage   +15 more
semanticscholar   +1 more source

Carcinoid heart disease: another step into the knowledge of a rare disease

Heart, 2023
With an incidence of 1/100 000 in the general population, carcinoid tumours are rare neuroendocrine malignancies (NETs). Mostly originating from the enterochromaffin cells of the gastrointestinal tract, they usually grow slowly over the years, secreting ...
A. Pavon, M. Guglielmo
semanticscholar   +1 more source

Carcinoid heart disease

Current Treatment Options in Cardiovascular Medicine, 2000
Carcinoid syndrome originates from metastatic carcinoid tumors localized in the gastrointestinal system, pancreas, biliary vessels, bronchi, ovaries, and testes; it is characterized by flushing, telangiectasias, diarrhea, bronchoconstriction, and fibrous endocardial plaques in the heart.
Vera H. Rigolin, Di Luzio S
openaire   +3 more sources

Carcinoid Heart Disease

Cardiology in Review, 2012
Carcinoid tumors are rare, indolent neuroendocrine tumors that are often associated with a syndrome characterized by episodic flushing, secretory diarrhea, bronchospasm, and hypotension-the carcinoid syndrome. Cardiac involvement occurs in one-half to two-thirds of patients with carcinoid syndrome and is associated with a worse clinical outcome ...
Wilbert S. Aronow, William H. Frishman, Chandrasekar Palaniswamy   +2 more
openaire   +3 more sources